Details of the Drug

General Information of Drug (ID: DMCIYNO)

Drug Name

Omidubicel

Indication

Disease Entry	ICD 11	Status	REF
Hematologic tumour	2B33.Y	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04260698) Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies. U.S. National Institutes of Health.